Trends in lipids and lipoproteins in US adults, 1988-2010.
By M. Carroll, B. Kit, D. Lacher, Susan T. Shero, M. Mussolino. 2012
284 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, Surgery
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
- H. Beltrán-Sánchez
- J. Armitage
- George Davey Smith
- Michael O. Harhay
- Meera Harhay
- P. Ridker
- S. McElligott
- Massimo F. Piepoli
In Public Health, Environmental and Occupational Health
In Surgery
- H. Beltrán-Sánchez
- J. Armitage
- George Davey Smith
- Michael O. Harhay
- Meera Harhay
- R. Collins
- M. Law
- P. Ridker
Citations in the corpus
- Prevalence and trends of Metabolic Syndrome in the adult US population, 1999–2010 (2013, result): “We observed pronounced declines in dyslipidemia, specifically in hypertriglyceridemia, results that align with previous studies (18).”
- Interpretation of the evidence for the efficacy and safety of statin therapy. (2016, background): “In addition, due to the tendency for statin therapy to be prescribed more commonly to individuals with elevated LDL cholesterol concentrations, the proportions with high levels have been preferentially reduced.(175,176) Representative data from population-based studies conducted before evidence of b”
- Metabolism Disrupting Chemicals and Metabolic Disorders (2016, unknown): “Total and LDL cholesterol have also been declining, and these favorable changes may be attributed to increased awareness and utilization of lipid lowering medications [26].”